GlassScriptPhysician profile
Izi D Obokhare
NPI 1437354784
$3,012.52
in general payments reported to CMS, 2019-2025
13 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $120 · 2021: $186 · 2022: $63.30 · 2023: $347 · 2024: $394 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163 · Travel and Lodging: $755 · Education: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,162.88 |
| Travel and Lodging | $755.25 |
| Education | $377.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,422.46 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,059.60 | 2023-2025 | Signia, Interstim, Ligasure |
| Ethicon US, LLC | $100.11 | 2020-2025 | Echelon Flex |
| Baxter Healthcare | $95.57 | 2022-2023 | Tisseel |
| Acell, INC. | $82.26 | 2020 | |
| Medtronic USA, INC. | $66.91 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $60.00 | 2025 | |
| Smith+Nephew, INC. | $45.00 | 2024 | |
| Kerecis Limited | $18.71 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Cook Medical LLC | $16.41 | 2019 | |
| Shire North American Group INC | $15.44 | 2019 | |
| Advanced Respiratory, INC | $15.39 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $14.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Izi Obokhare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.